Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
Authors
Keywords
-
Journal
CIRCULATION
Volume 145, Issue 4, Pages 242-255
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-01-05
DOI
10.1161/circulationaha.121.056355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
- (2020) Andreas Schäfer et al. CARDIOVASCULAR DRUGS AND THERAPY
- Conduct and reporting of individual participant data network meta-analyses need improvement
- (2020) Anna Chaimani BMC Medicine
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
- (2020) Giuseppe Boriani et al. THROMBOSIS AND HAEMOSTASIS
- Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale
- (2020) Anthony P Carnicelli et al. AMERICAN HEART JOURNAL
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies
- (2019) Anneka Mitchell et al. Journal of Clinical Medicine
- Effects of dabigatran according to age in atrial fibrillation
- (2017) Mandy N Lauw et al. HEART
- Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation
- (2016) Freddy Del-Carpio Munoz et al. AMERICAN JOURNAL OF CARDIOLOGY
- Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†
- (2015) Michelle L. O'Donoghue et al. EUROPEAN HEART JOURNAL
- Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment
- (2015) Hwanhee Hong et al. STATISTICS IN MEDICINE
- Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials
- (2014) Thomas Vanassche et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
- (2013) David A. Garcia et al. AMERICAN HEART JOURNAL
- Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy
- (2013) Kenneth W. Mahaffey et al. ANNALS OF INTERNAL MEDICINE
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation
- (2010) Michael D. Ezekowitz et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search